Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 1.24, which seems too high.
Good Sign:
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock Dividend Yield % is close to 10-year high.
During the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group's average Dividends Per Share Growth Rate was 191.40% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 36.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 42.60% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 26.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Tianjin Pharmaceutical Da Ren Tang Group was 62.20% per year. The lowest was -37.00% per year. And the median was 20.25% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Tianjin Pharmaceutical Da Ren Tang Group's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Tianjin Pharmaceutical Da Ren Tang Group was 1.32. The lowest was 0.28. And the median was 0.40.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is 1.24, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Tianjin Pharmaceutical Da Ren Tang Group Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
SGD 0.444834
2026-06-29
2026-06-30
2026-07-10
Cash Dividend
quarterly
SGD:EUR 0.670736
SGD 0.446390
2026-01-30
2026-02-02
2026-02-12
Cash Dividend
semi-annually
SGD:EUR 0.670132
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Tianjin Pharmaceutical Da Ren Tang Group's Dividend Yield (%) for Today is calculated as
Current Share Price is €2.44.
Tianjin Pharmaceutical Da Ren Tang Group's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.597506401304.
During the past 13 years, the highest Dividend Yield of Tianjin Pharmaceutical Da Ren Tang Group was 24.98%. The lowest was 0.70%. And the median was 1.56%.
Good Sign:
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd stock Dividend Yield % is close to 10-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin Pharmaceutical Da Ren Tang Group Dividends per Share Related Terms
Tianjin Pharmaceutical Da Ren Tang Group Dividends per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tianjin Pharmaceutical Da Ren Tang Group Dividends per Share Chart
Tianjin Pharmaceutical Da Ren Tang Group Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Pharmaceutical Da Ren Tang Group's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tianjin Pharmaceutical Da Ren Tang Group Dividend Yield % vs Drug Manufacturers Industry
Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) has a Dividends per Share of €0.46 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Tianjin Pharmaceutical Da Ren Tang Group and its competitors.
Is Tianjin Pharmaceutical Da Ren Tang Group's Dividends per Share too high?
Tianjin Pharmaceutical Da Ren Tang Group's current Dividends per Share is €0.46. Overall, Tianjin Pharmaceutical Da Ren Tang Group has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin Pharmaceutical Da Ren Tang Group's Dividends per Share compare to ZTS?
Tianjin Pharmaceutical Da Ren Tang Group's Dividends per Share of €0.46 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Tianjin Pharmaceutical Da Ren Tang Group and its competitors. Tianjin Pharmaceutical Da Ren Tang Group's current Dividends per Share is €0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin Pharmaceutical Da Ren Tang Group stock overvalued right now?
Based on GuruFocus' analysis, Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.64, compared to a current price of €2.44 — trading 48.8% above its estimated fair value. The current Dividends per Share is €0.46. Tianjin Pharmaceutical Da Ren Tang Group's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ), the current Dividends per Share is €0.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tianjin Pharmaceutical Da Ren Tang Group (STU:2TZ) Overvalued in 2026?
Based on GuruFocus' analysis, Tianjin Pharmaceutical Da Ren Tang Group stock appears to be overvalued.
The current stock price of €2.44 is trading 48.8% above its estimated GF Value™ of €1.64.
GuruFocus considers Tianjin Pharmaceutical Da Ren Tang Group to be Significantly Overvalued.
Key valuation signals for STU:2TZ:
Dividends per Share: €0.46
GF Value™: €1.64 vs. price of €2.44 (48.8% above fair value)
No single metric tells the full story. See the STU:2TZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tianjin Pharmaceutical Da Ren Tang Group Business Description
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company is engaged in the production and sale of traditional Chinese medicine, Western medicine, healthcare products, and investment holding. It operates in two segments, namely the Chinese Medicine segment and the Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures Western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese medicine.
71GF Score
Get the complete analysis for STU:2TZ
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2TZ has been successfully added to your 
